LINKS
Homepage
Presidents of APPA  
APPA Council
Awards
Membership
Past Programs
2009 Program
Poster Session
Publications
Registration form
Comprehensive Psychiatry
Contact us

logo.jpg (9207 bytes)

The American Psychopathological Association

SCHIZOPHRENIA: LIFETIME CONTRIBUTIONS TO RESEARCH

The 91st Annual Meeting March 1-3, 2001

Crowne Plaza Hotel, New York, NY

Scientific Program

March 1, March 2, March 3, 2001

 

Research progress in the understanding and treatment of a complex illness like schizophrenia is incremental and is the result of the efforts of many investigators. This APPA meeting will explore that progress through the careers of individuals who have made sustained contributions to our knowledge. Asking pivotal researchers to describe their personal growth, ideas and understanding of problems in schizophrenia will provide an overview of the field that will allow us to see where we came from, what our current knowledge is and our future prospects.

Thursday, March 1, 2001
   
8:30 -- 9:15 Registration
9:15 -- 9:30 Welcome, Introduction and Presentation of Robins-Guze Award and Student Leadership Awards
Nina R. Schooler, PhD, President APPA
   
SESSION 1 Insuring the Future
Chair: Nina R. Schooler, PhD, Hillside Hospital
   
9:30 -- 9:50 From Art and Architecture to Building Schizophrenia Research Careers
  Connie Lieber, National Alliance for Research on Schizophrenia and Depression
   
9:50 -- 10:10 Translational Research and the Analysis of Brain Dysfunction in Schizophrenia
  Daniel Javitt, MD, PhD, Nathan Kline Institute
   
10:10 -- 10:30 Prospects for Pharmacogenomic Studies in Schizophrenia
  Anil Malhotra, MD, Hillside Hospital
10:30 -- 10:50 Coffee Break
10:50 -- 11:10

Early Origins of Schizophrenia: One Lifetime is not Enough
  Ezra Susser, MD, DrPH, New York State Psychiatric Institute
11:10 -- 11:30

Research in the Biology of Psychosis: From Sleep to Synapses
  Matcheri Keshavan, MD, Western Psychiatric Institute and Clinic
11:30 -- 11:50 Testing Basic Concepts in Clinical Trials and Outcome Research
  Robert Conley, MD, Maryland Psychiatric Research Center
11:50 -- 12:15 General Discussion
 
SESSION 2 The Brain
Chair: Jack M. Gorman, MD, New York State Psychiatric Institute
   
12:15 -- 12:45 Prefrontal Cortical Function in Schizophrenia: A Career Trek on the Royal Road from Phenomenology to Genetic Causation
  Daniel Weinberger, MD, National Institute of Mental Health
12:45 -- 12:55 Discussion
12:55 -- 2:30 LUNCH
2:30 -- 3:00 Prefrontal Cortex: Memory, Mind and Madness
  Patricia Goldman-Rakic, PhD
3:00 -- 3:10 Discussion
3:10 -- 3:30 Coffee Break
3:30 -- 4:00 Cognitive Dysfunction in Schizophrenia: Molecular and Circuitry Alterations in the Prefrontal Cortex
David Lewis, MD, Western Psychiatric Institute and Clinic
4:00 -- 4:10 Discussion
4:10 -- 4:50 Discussant and General Discussion
  Jack M. Gorman, MD
5:30 -- 7:30 Poster reception
Friday March 2, 2001
SESSION 3 Characterizing the Illness
Chair: Murray Alpert, PhD New York University
   
9:00 -- 9:30 Decharacterizing the Illness: A Strategy for the Middle Game
  Philip Holzman, PhD, Harvard University
9:30 -- 9:40 Discussion
 
9:40 -- 10:20 Schizophrenia Outcomes Research: Lessons Learned in the Life Course of an Investigator
  Evelyn Bromet, PhD, SUNY-Stony Brook
10:20 -- 10:30 Discussion
10:30 -- 10:50 Coffee Break
10:50 -- 11:20 Finding a Disease Entity Within the Schizophrenia Syndrome
  William Carpenter, MD, Maryland Psychiatric Research Center
 
11:20 -- 11:30 Discussion
11:30 -- 12:00 Discussant and General Discussion
  Murray Alpert, PhD
12:00 -- 12:30 APPA Business Meeting (Members Only)
   
12:30 -- 2:00 LUNCH
SESSION 4 Evolving Treatment Strategies
Chair: Barry Lebowitz, PhD, National Institute of Mental Health
2:00 -- 2:30 Pharmacologic Treatment of Schizophrenia
  John M. Kane, MD, Hillside Hospital
2:30 -- 2:40 Discussion
2:40 -- 3:10 Evolution of Psychosocial Treatment: A Personal Odyssey
  Hoch Awardee Address: Gerard Hogarty, MSW, Western Psychiatric Institute and Clinic
3:10 -- 3:20 Discussion
3:20 -- 3:40 Coffee Break
3:40 -- 4:10 Integration of Pharmacologic and Psychosocial Treatments: Long Term Outcomes
Presidential Address: Nina R. Schooler, PhD, Hillside Hospital
 
4:10 -- 4:20 Discussion
4:20 -- 4:50 Reciprocal Influences Between Research on Treatment, Assessment, and the Basis of Impairment in Schizophrenia
  Alan S. Bellack, PhD, University of Maryland School of Medicine
   
4:50 -- 5:00 Discussion
5:00 -- 5:30 Discussant and General Discussion
  Barry Lebowitz, PhD
Saturday, March 3, 2001
SESSION 5 Detection, Prevention and Re-direction
Chair: Robert Spitzer, MD, Zubin Award Recipient, New York State Psychiatric Institute
9:00 -- 9:30 Schizotaxia: A False Hope or a True Pathway to Early Detection and Prevention of Schizophrenia?
  Ming Tsuang, MD, PhD, Harvard University
9:30 -- 9:40 Discussion
9:40 -- 10:00 Coffee Break
10:00 -- 10:30 Prediction to Prevention: Problems and Promises
  Barbara Cornblatt, PhD, Hillside Hospital
10:30 -- 10:40 Discussion
10:40 -- 11:10 Diagnosis, Development, and Dysconnectivity: Facts, Fashions or Fables
  Robin Murray, MD, Institute of Psychiatry, London
11:10 -- 11:20 Discussion
11:20 -- 11:40 Discussant and General Discussion
Robert Spitzer, MD